Revolution Medicines: Peers

The FY2025 (Dec) proxy of Revolution Medicines names 17 peer companies for pay. Among Revolution Medicines and these peers, CEO pay was 2nd highest of 5 and total shareholder return was 3rd highest of 5.

2nd highest of 5in Revolution Medicines and its pay peers, FY2025 (Dec) by CEO pay:

$7.7M$19.2M

3rd highest of 5in Revolution Medicines and its pay peers, FY2025 (Dec) by total shareholder return:

$34$524

Pay peer group, FY2025 (Dec) proxy

Madrigal Pharmaceuticals
Ionis Pharmaceuticals
Krystal Biotech
CRISPR Therapeutics AG
Apellis PharmaceuticalsNot disclosedNot disclosed
Arrowhead PharmaceuticalsNot disclosedNot disclosed
ArvinasNot disclosedNot disclosed
Blueprint MedicinesNot disclosedNot disclosed
Cerevel TherapeuticsNot disclosedNot disclosed
CytokineticsNot disclosedNot disclosed
Denali TherapeuticsNot disclosedNot disclosed
Intellia TherapeuticsNot disclosedNot disclosed
Intra-Cellular TherapeuticsNot disclosedNot disclosed
NuvalentNot disclosedNot disclosed
Roivant SciencesNot disclosedNot disclosed
SpringWorks TherapeuticsNot disclosedNot disclosed
VaxcyteNot disclosedNot disclosed
17 companies

Changes by year

FY2025 (Dec) proxy

  • AddedIonis Pharmaceuticalspay peer groupbecause they met the criteria set forth above
  • AddedKrystal Biotechpay peer groupbecause they met the criteria set forth above
  • AddedNuvalentpay peer groupbecause they met the criteria set forth above
  • AddedRoivantpay peer groupbecause they met the criteria set forth above
  • AddedVaxcytepay peer groupbecause they met the criteria set forth above
  • RemovedArcus Biosciencespay peer groupbecause of corporate transactions involving these companies and/or because they no longer met the criteria set forth above
  • RemovedDay One Biopharmaceuticalspay peer groupbecause of corporate transactions involving these companies and/or because they no longer met the criteria set forth above
  • RemovedKaruna Therapeuticspay peer groupbecause of corporate transactions involving these companies and/or because they no longer met the criteria set forth above
  • RemovedMirati Therapeuticspay peer groupbecause of corporate transactions involving these companies and/or because they no longer met the criteria set forth above
  • RemovedRelay Therapeuticspay peer groupbecause of corporate transactions involving these companies and/or because they no longer met the criteria set forth above
  • RemovedXencorpay peer groupbecause of corporate transactions involving these companies and/or because they no longer met the criteria set forth above

FY2024 (Dec) proxy

  • AddedApellis Pharmaceuticalspay peer group
  • AddedArrowhead Pharmaceuticalspay peer group
  • AddedBlueprint Medicinespay peer group
  • AddedCRISPR Therapeutics AGpay peer group
  • AddedCerevel Therapeuticspay peer group
  • AddedCytokineticspay peer group
  • AddedIntelliapay peer group
  • RemovedAlectorpay peer groupbecause of corporate transactions involving these companies and/or because they no longer met the criteria set forth above
  • RemovedAllogene Therapeuticspay peer groupbecause of corporate transactions involving these companies and/or because they no longer met the criteria set forth above
  • RemovedFate Therapeuticspay peer groupbecause of corporate transactions involving these companies and/or because they no longer met the criteria set forth above
  • RemovedIGM Biosciencespay peer groupbecause of corporate transactions involving these companies and/or because they no longer met the criteria set forth above
  • RemovedImmunoGenpay peer groupbecause of corporate transactions involving these companies and/or because they no longer met the criteria set forth above
  • RemovedIovance Biotherapeuticspay peer groupbecause of corporate transactions involving these companies and/or because they no longer met the criteria set forth above
  • RemovedKura Oncologypay peer groupbecause of corporate transactions involving these companies and/or because they no longer met the criteria set forth above
  • RemovedNurix Therapeuticspay peer groupbecause of corporate transactions involving these companies and/or because they no longer met the criteria set forth above
  • RemovedReplimune Grouppay peer groupbecause of corporate transactions involving these companies and/or because they no longer met the criteria set forth above
  • RemovedZentalis Pharmaceuticalspay peer groupbecause of corporate transactions involving these companies and/or because they no longer met the criteria set forth above

FY2023 (Dec) proxy

  • AddedAlector Therapeuticspay peer groupbecause they met the criteria set forth above
  • AddedDay One Biopharmaceuticalspay peer groupbecause they met the criteria set forth above
  • AddedDenali Therapeuticspay peer groupbecause they met the criteria set forth above
  • AddedFate Therapeuticspay peer groupbecause they met the criteria set forth above
  • RemovedC4 Therapeuticspay peer groupbecause of corporate transactions involving these companies
  • RemovedDicerna Pharmaceuticalspay peer groupbecause of corporate transactions involving these companies
  • RemovedRubius Therapeuticspay peer groupbecause of corporate transactions involving these companies
  • RemovedTurning Point Therapeuticspay peer groupbecause of corporate transactions involving these companies

The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.